%0 Journal Article %A Iyas Daghlas %A Nathan Varady %T Body mass index and carpal tunnel syndrome: a Mendelian randomization study %D 2020 %R 10.1101/19011536 %J medRxiv %P 19011536 %X Introduction We investigated whether higher body mass index (BMI) may causally increase risk of carpal tunnel syndrome using Mendelian randomization (MR).Methods The exposure included genetic instruments comprising independent variants associated with BMI (n=322,154). Associations of these variants with CTS were obtained from a genome-wide association study conducted in UK Biobank (UKB; 12,312 cases/389,344 controls) with replication in the FinnGen cohort (4,505 cases/86,854 controls). Causal effects were estimated using inverse-variance weighted regression, and sensitivity analyses probed robustness of results.Results A 1-standard deviation (4.7kg/m2) increase in genetically instrumented BMI increased the odds of CTS in UKB (OR 1.73, 95% CI 1.48-2.02, P=2.68×10−12; 16.8 additional cases per 1000 person-years [95% CI 11.0-23.5]). This effect was consistent in the replication sample and across sensitivity analyses.Discussion These data support a causal effect of higher BMI on susceptibility to CTS. Clinical investigations of weight loss for treatment of CTS may be warranted.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was obtained for the present work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll summary statistics used for the present analysis are publically available. %U https://www.medrxiv.org/content/medrxiv/early/2020/05/12/19011536.full.pdf